Thursday, July 17, 2014 9:00:30 AM
StemCells Inc. Problems?
Whistle-Blower Alarmed at Stem Cell Work
By ELIZABETH WARMERDAM
Wednesday, July 16, 2014 Last Update: 7:43 AM PT
OAKLAND, Calif. (CN) - A stem cell research company fired a manager after he complained that deficiencies in the company's cell lines put patients at risk of infection or death during clinical trials, the man claims in court.
Rob Williams sued StemCells Inc. on Monday in Alameda County Court, alleging wrongful termination, retaliation and violation of the California False Claims Act.
To receive millions of dollars in government funding, including grants from the California Institute for Regenerative Medicine, StemCells claims that its manufacturing processes yield stem cells that are "safe for human stem cell transplantation," the complaint states.
StemCells must follow a set of standards - Good Manufacturing Practices - set forth by the FDA to protect the public, according to the complaint.
Williams says he was hired as the company's senior manager of manufacturing in December 2013 to oversee its manufacturing facility, where stem cell cultures are cultivated for use in clinical trials.
"Shortly after beginning his employment, plaintiff noted poor sterile technique, failure to adhere to current Good Manufacturing Practices in the company's manufacturing process, and substantial deficiencies in the company's Manual Aseptic Processing of HuCNS-SC (Human Central Nervous System Stem Cells) cell lines - failure and deficiencies that put patients at risk of infection or death during ongoing clinical trials," Williams says.
Williams claims he also saw manufacturing deviations during cryopreservation of Working Cell Bank lots, leading to numerous stem cell lots with dangerously high numbers of damaged cells.
"Knowing that these cells were to be injected into human patients, and that the high level of damaged cells and the possibility of contaminating microorganisms could cause serious harm to patients, plaintiff immediately took his concerns to upper management. He also noted that the use of adulterated stem cells lots could skew patient test results, effectively jeopardizing data behind years of clinical trials and research," the complaint states.
Williams says he was told to conceal his findings from reports, and the company suspended him shortly thereafter.
Williams sent emails to company leadership and members of the company's executive team reiterating his concerns about the processes used to create the stem cell lines for use in human patients. He also described the suspension he faced as retaliation for bringing the issue out into the open, the complaint states.
StemCells fired Williams a few weeks later, he says.
Williams seeks punitive damages.
He is represented by Daniel Velton with Velton Zegelman, of Sunnyvale.
StemCells did not immediately respond to a request for comment.
Recent STEM News
- Stem Announces PowerTrack™ APM for Comprehensive Solar and Storage Energy Portfolio Management • Business Wire • 05/02/2024 08:10:00 PM
- Stem Announces First Quarter 2024 Results • Business Wire • 05/02/2024 08:05:00 PM
- Stem Announces Appointment of AI Industry Leader as New Independent Director • Business Wire • 04/19/2024 08:30:00 PM
- Stem Announces First Quarter 2024 Earnings Results Conference Call • Business Wire • 04/16/2024 12:30:00 PM
- Stem’s PowerBidder™ Pro Selected by Two CCAs in CAISO • Business Wire • 03/19/2024 12:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/11/2024 02:24:51 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 09:43:28 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 09:36:56 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 09:36:38 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 09:35:43 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 09:34:55 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 09:34:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 09:33:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 10:04:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:25:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:25:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:23:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:23:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:23:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:22:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:22:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:20:25 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 05:18:17 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 01:27:52 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 01:26:31 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM